Pathogenesis and virulence of Heartland virus

References

• McMullan LK, Folk SM, Kelly AJ, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367(9):834–10. doi: 10.1056/NEJMoa1203378
   PubMed Web of Science ®Google Scholar
• Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–1532. doi: 10.1056/NEJMoa1010095
   PubMed Web of Science ®Google Scholar
• Kuhn JH, Adkins S, Alkhovsky SV, et al. 2022 taxonomic update of phylum negarnaviricota (Riboviria: orthornavirae), including the large orders bunyavirales and Mononegavirales. Arch Virol. 2022;167(12):2857–2906. doi: 10.1007/s00705-022-05546-z
   PubMed Web of Science ®Google Scholar
• Savage HM, Godsey MS, Lambert A, et al. First detection of heartland virus (bunyaviridae: phlebovirus) from field collected arthropods. Am J Trop Med Hyg. 2013;89(3):445–452. doi: 10.4269/ajtmh.13-0209
   PubMed Web of Science ®Google Scholar
• Savage HM, Godsey MS Jr., Panella NA, et al. Surveillance for heartland virus (bunyaviridae: phlebovirus) in Missouri during 2013: first detection of virus in adults of amblyomma americanum (Acari: ixodidae). J Med Entomol. 2016;53(3):607–612. doi: 10.1093/jme/tjw028
   PubMed Web of Science ®Google Scholar
• Godsey MS, Savage HM, Burkhalter KL, et al. Transmission of heartland virus (bunyaviridae: phlebovirus) by experimentally infected amblyomma americanum (Acari: ixodidae). J Med Entomol. 2016;53(5):1226–1233. doi: 10.1093/jme/tjw080
   PubMed Web of Science ®Google Scholar
• Tuten HC, Burkhalter KL, Noel KR, et al. Heartland virus in humans and ticks, Illinois, USA, 2018–2019. Emerg Infect Dis. 2020;26(7):1548–1552. doi: 10.3201/eid2607.200110
   PubMed Web of Science ®Google Scholar
• Newman BC, Sutton WB, Moncayo AC, et al. Heartland virus in Lone star ticks, Alabama, USA. Emerg Infect Dis. 2020;26(8):1954–1956. doi: 10.3201/eid2608.200494
   PubMed Web of Science ®Google Scholar
• Romer Y, Adcock K, Wei Z, et al. Isolation of heartland virus from Lone star ticks, Georgia, USA, 2019. Emerg Infect Dis. 2022;28(4):786–792. doi: 10.3201/eid2804.211540
   PubMed Web of Science ®Google Scholar
• Aziati ID, Jnr DM, Antia A, et al. Prevalence of bourbon and heartland viruses in field collected ticks at an environmental field station in st. Louis County, Missouri, USA. Ticks Tick Borne Dis. 2023;14(1):102080. doi: 10.1016/j.ttbdis.2022.102080
   PubMed Web of Science ®Google Scholar
• Brault AC, Savage HM, Duggal NK, et al. Heartland virus epidemiology, vector association, and disease potential. Viruses. 2018;10(9):498. doi: 10.3390/v10090498
   PubMed Web of Science ®Google Scholar
• Staples JE, Pastula DM, Panella AJ, et al. Investigation of heartland virus disease throughout the United States, 2013–2017. Open Forum Inf Dis. 2020;7(5):ofaa125. doi: 10.1093/ofid/ofaa125
   PubMed Web of Science ®Google Scholar
• Cumbie AN, Trimble RN, Eastwood G. Pathogen spillover to an invasive tick species: first detection of Bourbon virus in haemaphysalis longicornis in the United States. Pathogens. 2022;11(4):11. doi: 10.3390/pathogens11040454
   Web of Science ®Google Scholar
• Raney WR, Perry JB, Hermance ME. Transovarial transmission of Heartland virus by invasive Asian longhorned ticks under laboratory conditions. Emerg Infect Dis. 2022;28(3):726–729. doi: 10.3201/eid2803.210973
   PubMed Web of Science ®Google Scholar
• Riemersma KK, Komar N. Heartland virus neutralizing antibodies in vertebrate wildlife, United States, 2009–2014. Emerg Infect Dis. 2015;21(10):1830–1833. doi: 10.3201/eid2110.150380
   PubMed Web of Science ®Google Scholar
• Bosco-Lauth AM, Panella NA, Root JJ, et al. Serological investigation of heartland virus (bunyaviridae: phlebovirus) exposure in wild and domestic animals adjacent to human case sites in Missouri 2012–2013. Am J Trop Med Hyg. 2015;92(6):1163–1167. doi: 10.4269/ajtmh.14-0702
   PubMed Web of Science ®Google Scholar
• Clarke LL, Ruder MG, Mead DG, et al. Heartland virus exposure in white-tailed deer in the Southeastern United States, 2001–2015. Am J Trop Med Hyg. 2018;99(5):1346–1349. doi: 10.4269/ajtmh.18-0555
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Kirino Y, Fujimoto S, et al. Direct transmission of severe fever with thrombocytopenia syndrome virus from domestic cat to veterinary personnel. Emerg Infect Dis. 2020;26(12):2994–2998. doi: 10.3201/eid2612.191513
   PubMed Web of Science ®Google Scholar
• Tang X, Wu W, Wang H, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis. 2013;207(5):736–739. doi: 10.1093/infdis/jis748
   PubMed Web of Science ®Google Scholar
• Fang X, Hu J, Peng Z, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome bunyavirus human-to-human transmission. PLOS Negl Trop Dis. 2021;15(4):e0009037. doi: 10.1371/journal.pntd.0009037
   PubMed Web of Science ®Google Scholar
• Pastula DM, Turabelidze G, Yates KF, et al. Notes from the field: heartland virus disease - United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63(12):270–271.
   PubMed Web of Science ®Google Scholar
• Decker MD, Morton CT, Moncayo AC. One confirmed and 2 suspected cases of heartland virus disease. Clin Infect Dis. 2020;71(12):3237–3240. doi: 10.1093/cid/ciaa647
   PubMed Web of Science ®Google Scholar
• Muehlenbachs A, Fata CR, Lambert AJ, et al. Heartland virus-associated death in tennessee. Clin Infect Dis. 2014;59(6):845–850. doi: 10.1093/cid/ciu434
   PubMed Web of Science ®Google Scholar
• Fill MA, Compton ML, EC M, et al. Novel clinical and pathologic findings in a heartland virus-associated death. Clin Infect Dis. 2017;64:510–512. doi: 10.1093/cid/ciw766
   PubMed Web of Science ®Google Scholar
• Carlson AL, Pastula DM, Lambert AJ, et al. Heartland virus and hemophagocytic lymphohistiocytosis in immunocompromised patient, Missouri, USA. Emerg Infect Dis. 2018;24(5):893–897. doi: 10.3201/eid2405.171802
   PubMed Web of Science ®Google Scholar
• Ahlers CG, Matthews H, Perez R, et al. Secondary hemophagocytic lymphohistiocytosis due to heartland virus. BMJ Case Rep. 2022;15(12):e253082. doi: 10.1136/bcr-2022-253082
   PubMedGoogle Scholar
• Liu S, Kannan S, Meeks M, et al. Fatal case of heartland virus disease acquired in the Mid-Atlantic Region, United States. Emerg Infect Dis. 2023;29(5):992–996. doi: 10.3201/eid2905.221488
   PubMed Web of Science ®Google Scholar
• Bosco-Lauth AM, Calvert AE, Root JJ, et al. Vertebrate host susceptibility to heartland virus. Emerg Infect Dis. 2016;22(12):2070–2077. doi: 10.3201/eid2212.160472
   PubMed Web of Science ®Google Scholar
• Clarke LL, Ruder MG, Mead D, et al. Experimental infection of white-tailed deer (odocoileus virginanus) with heartland virus. Am J Trop Med Hyg. 2018;98(4):1194–1196. doi: 10.4269/ajtmh.17-0963
   PubMed Web of Science ®Google Scholar
• Fujii H, Tani H, Egawa K, et al. Susceptibility of type I interferon receptor knock-out mice to heartland bandavirus (HRTV) infection and efficacy of favipiravir and ribavirin in the treatment of the mice infected with HRTV. Viruses. 2022;14(8):1668. doi: 10.3390/v14081668
   PubMed Web of Science ®Google Scholar
• Fujii H, Fukushi S, Yoshikawa T, et al. Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with heartland virus. Virus Res. 2023;340:199301. doi: 10.1016/j.virusres.2023.199301
   PubMed Web of Science ®Google Scholar
• Reynolds ES, Wooldridge JT, Stevenson HL, et al. The lone star tick, amblyomma americanum, salivary factors exacerbate the clinical outcome of heartland virus disease in a small animal model. Sci Rep. 2023;13(1):13304. doi: 10.1038/s41598-023-40397-x
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Inagaki T, Tajima S, et al. Reverse genetics system for Heartland bandavirus: NSs protein contributes to Heartland bandavirus virulence. J Virol. 2022;96(7):e0004922. doi: 10.1128/jvi.00049-22
   PubMed Web of Science ®Google Scholar
• Westover JB, Rigas JD, Van Wettere AJ, et al. Heartland virus infection in hamsters deficient in type I interferon signaling: protracted disease course ameliorated by favipiravir. Virology. 2017;511:175–183. doi: 10.1016/j.virol.2017.08.004
   PubMed Web of Science ®Google Scholar
• Carty M, Guy C, Bowie AG. Detection of viral infections by innate immunity. Biochem Pharmacol. 2021;183:114316. doi: 10.1016/j.bcp.2020.114316
   PubMed Web of Science ®Google Scholar
• Min YQ, Ning YJ, Wang H, et al. A RIG-I–like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. J Biol Chem. 2020;295(28):9691–9711. doi: 10.1074/jbc.RA120.013973
   PubMed Web of Science ®Google Scholar
• Yamada S, Shimojima M, Narita R, et al. RIG-I-Like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines/chemokines in a severe fever with thrombocytopenia syndrome virus infection mouse model. J Virol. 2018;92(13). doi: 10.1128/JVI.02246-17
   Web of Science ®Google Scholar
• Song P, Zheng N, Zhang L, et al. Downregulation of interferon-β and inhibition of TLR3 expression are associated with fatal outcome of severe fever with thrombocytopenia syndrome. Sci Rep. 2017;7(1):6532. doi: 10.1038/s41598-017-06921-6
   PubMedGoogle Scholar
• Peng C, Wang H, Zhang W, et al. Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2016;43:37–42. doi: 10.1016/j.ijid.2015.12.009
   PubMed Web of Science ®Google Scholar
• Li S, Li H, Zhang YL, et al. SFTSV infection induces BAK/BAX-dependent mitochondrial DNA release to trigger NLRP3 inflammasome activation. Cell Rep. 2020;30(13):4370–4385.e7. doi: 10.1016/j.celrep.2020.02.105
   PubMed Web of Science ®Google Scholar
• Dalskov L, Gad HH, Hartmann R. Viral recognition and the antiviral interferon response. Embo J. 2023;42(14):e112907. doi: 10.15252/embj.2022112907
   PubMed Web of Science ®Google Scholar
• Mo Q, Xu Z, Deng F, et al. Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly. PLOS Pathog. 2020;16(12):e1009129. doi: 10.1371/journal.ppat.1009129
   PubMed Web of Science ®Google Scholar
• Miura TA, Carlson JO, Beaty BJ, et al. Expression of human MxA protein in mosquito cells interferes with LaCrosse virus replication. J Virol. 2001;75(6):3001–3003. doi: 10.1128/JVI.75.6.3001-3003.2001
   PubMed Web of Science ®Google Scholar
• Kochs G, Janzen C, Hohenberg H, et al. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci U S A. 2002;99(5):3153–3158. doi: 10.1073/pnas.052430399
   PubMed Web of Science ®Google Scholar
• Reichelt M, Stertz S, Krijnse-Locker J, et al. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic. 2004;5(10):772–784. doi: 10.1111/j.1600-0854.2004.00219.x
   PubMed Web of Science ®Google Scholar
• Andersson I, Bladh L, Mousavi-Jazi M, et al. Human MxA protein inhibits the replication of crimean-congo hemorrhagic fever virus. J Virol. 2004;78(8):4323–4329. doi: 10.1128/JVI.78.8.4323-4329.2004
   PubMed Web of Science ®Google Scholar
• Bridgen A, Dalrymple DA, Weber F, et al. Inhibition of dugbe nairovirus replication by human MxA protein. Virus Res. 2004;99(1):47–50. doi: 10.1016/j.virusres.2003.10.002
   PubMed Web of Science ®Google Scholar
• Habjan M, Penski N, Wagner V, et al. Efficient production of rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology. 2009;385(2):400–408. doi: 10.1016/j.virol.2008.12.011
   PubMed Web of Science ®Google Scholar
• Chang M, Min YQ, Xu Z, et al. Host factor MxA restricts dabie bandavirus infection by targeting the viral NP protein to inhibit NP-RdRp interaction and ribonucleoprotein activity. J Virol. 2024;98(1):e0156823. doi: 10.1128/jvi.01568-23
   PubMed Web of Science ®Google Scholar
• Mudhasani R, Tran JP, Retterer C, et al. IFITM-2 and IFITM-3 but not IFITM-1 restrict rift Valley fever virus. J Virol. 2013;87(15):8451–8464. doi: 10.1128/JVI.03382-12
   PubMed Web of Science ®Google Scholar
• Xu-Yang Z, Pei-Yu B, Chuan-Tao Y, et al. Interferon-induced transmembrane protein 3 inhibits hantaan virus infection, and its single nucleotide polymorphism rs12252 influences the severity of hemorrhagic fever with renal syndrome. Front Immunol. 2016;7:535. doi: 10.3389/fimmu.2016.00535
   PubMed Web of Science ®Google Scholar
• Du S, Wang Y, Wang J, et al. IFITM3 inhibits severe fever with thrombocytopenia syndrome virus entry and interacts with viral gc protein. J Med Virol. 2024;96(3):e29491. doi: 10.1002/jmv.29491
   PubMedGoogle Scholar
• Hevey MA, JA O, Jagger BW, et al. Heartland virus infection in a heart transplant recipient from the Heartland. Transplant Infectious Dis. 2019;21(4):e13098. doi: 10.1111/tid.13098
   PubMed Web of Science ®Google Scholar
• Zhang SF, Yang ZD, Huang ML, et al. Preexisting chronic conditions for fatal outcome among SFTS patients: an observational cohort study. PLOS Negl Trop Dis. 2019;13(5):e0007434. doi: 10.1371/journal.pntd.0007434
   PubMed Web of Science ®Google Scholar
• Wang M, Huang P, Liu W, et al. Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: a five-year retrospective case-control study. Front Microbiol. 2022;13:1033946. doi: 10.3389/fmicb.2022.1033946
   PubMed Web of Science ®Google Scholar
• Ge HH, Wang G, Guo PJ, et al. Coinfections in hospitalized patients with severe fever with thrombocytopenia syndrome: a retrospective study. J Med Virol. 2022;94(12):5933–5942. doi: 10.1002/jmv.28093
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Y, Xu Y. Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections. J Med Virol. 2022;94(12):5916–5921. doi: 10.1002/jmv.28059
   PubMed Web of Science ®Google Scholar
• Sun J, Min YQ, Li Y, et al. Animal model of severe fever with thrombocytopenia syndrome virus infection. Front Microbiol. 2021;12:797189. doi: 10.3389/fmicb.2021.797189
   PubMed Web of Science ®Google Scholar
• Feng K, Zhang H, Jiang Z, et al. SFTS bunyavirus NSs protein sequestrates mTOR into inclusion bodies and deregulates mTOR-ULK1 signaling, provoking pro-viral autophagy. J Med Virol. 2023;95(1):e28371. doi: 10.1002/jmv.28371
   PubMed Web of Science ®Google Scholar
• Zhao J, Lu QB, Li H, et al. Sex differences in case fatality rate of patients with severe fever with thrombocytopenia syndrome. Front Microbiol. 2021;12:738808. doi: 10.3389/fmicb.2021.738808
   PubMed Web of Science ®Google Scholar
• Qu B, Qi X, Wu X, et al. Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol. 2012;86(16):8388–8401. doi: 10.1128/JVI.00612-12
   PubMed Web of Science ®Google Scholar
• Wu X, Qi X, Qu B, et al. Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies. J Virol. 2014;88(6):3067–3076. doi: 10.1128/JVI.03510-13
   PubMed Web of Science ®Google Scholar
• Ning YJ, Wang M, Deng M, et al. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform. J Mol Cell Biol. 2014;6(4):324–337. doi: 10.1093/jmcb/mju015
   PubMed Web of Science ®Google Scholar
• Santiago FW, Covaleda LM, Sanchez-Aparicio MT, et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol. 2014;88(8):4572–4585. doi: 10.1128/JVI.03021-13
   PubMed Web of Science ®Google Scholar
• Ning YJ, Feng K, Min YQ, et al. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J Virol. 2015;89(8):4227–4236. doi: 10.1128/JVI.00154-15
   PubMed Web of Science ®Google Scholar
• Ning YJ, Mo Q, Feng K, et al. Interferon-γ-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1. Front Immunol. 2019;10:1182. doi: 10.3389/fimmu.2019.01182
   PubMed Web of Science ®Google Scholar
• Choi Y, Park SJ, Sun Y, et al. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat Microbiol. 2019;4(3):429–437. doi: 10.1038/s41564-018-0329-x
   PubMed Web of Science ®Google Scholar
• Hong Y, Bai M, Qi X, et al. Suppression of the IFN-α and -β induction through sequestering IRF7 into viral inclusion bodies by nonstructural protein NSs in severe fever with thrombocytopenia syndrome bunyavirus infection. J Immunol. 2019;202(3):841–856. doi: 10.4049/jimmunol.1800576
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu Y, Zhang R, et al. Nonstructural protein NSs hampers cellular antiviral response through LSm14A during severe fever with thrombocytopenia syndrome virus infection. J Immunol. 2021;207(2):590–601. doi: 10.4049/jimmunol.2100148
   PubMed Web of Science ®Google Scholar
• Ning YJ, Feng K, Min YQ, et al. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase–IRF3 transcription factor interaction and signaling required for interferon induction. J Biol Chem. 2017;292(40):16722–16733. doi: 10.1074/jbc.M117.805127
   PubMed Web of Science ®Google Scholar
• Rezelj L VV, Chaudhary P, Elliott V, et al. Differential antagonism of human innate immune responses by tick-borne phlebovirus nonstructural proteins. mSphere. 2017;2. doi: 10.1128/mSphere.00234-17
   PubMed Web of Science ®Google Scholar
• Moriyama M, Igarashi M, Koshiba T, et al. Two conserved amino acids within the NSs of severe fever with thrombocytopenia syndrome phlebovirus are essential for anti-interferon activity. J Virol. 2018;92(19): doi: 10.1128/JVI.00706-18
   Web of Science ®Google Scholar
• Feng K, Deng F, Hu Z, et al. Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1. J Biol Chem. 2019;294(24):9503–9517. doi: 10.1074/jbc.RA118.006563
   PubMed Web of Science ®Google Scholar
• Liu S, Su Y, Lu Z, et al. The SFTSV nonstructural proteins induce autophagy to promote viral replication via interaction with Vimentin. J Virol. 2023;97(4):e0030223. doi: 10.1128/jvi.00302-23
   PubMed Web of Science ®Google Scholar
• Yan JM, Zhang WK, Yan LN, et al. Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress. Autophagy. 2022;18(7):1599–1612. doi: 10.1080/15548627.2021.1994296
   PubMed Web of Science ®Google Scholar
• Hofmann H, Li X, Zhang X, et al. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol. 2013;87(8):4384–4394. doi: 10.1128/JVI.02628-12
   PubMed Web of Science ®Google Scholar
• Tani H, Shimojima M, Fukushi S, et al. Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus. J Virol. 2016;90(11):5292–5301. doi: 10.1128/JVI.00110-16
   PubMed Web of Science ®Google Scholar
• Sun Y, Qi Y, Liu C, et al. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J Virol. 2014;88(1):237–248. doi: 10.1128/JVI.02141-13
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng X, Wang Q, et al. CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Sci Adv. 2023;9(31):eadg6856. doi: 10.1126/sciadv.adg6856
   PubMed Web of Science ®Google Scholar
• Zhang LK, Wang B, Xin Q, et al. Quantitative proteomic analysis reveals unfolded-protein response involved in severe fever with thrombocytopenia syndrome virus infection. J Virol. 2019;93(10). doi: 10.1128/JVI.00308-19
   Web of Science ®Google Scholar
• Park SJ, Kim YI, Park A, et al. Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis. Nat Microbiol. 2019;4(3):438–446. doi: 10.1038/s41564-018-0317-1
   PubMed Web of Science ®Google Scholar
• Chen L, Chen T, Li R, et al. Recent advances in the study of the immune escape mechanism of SFTSV and its therapeutic agents. Viruses. 2023;15(4):940. doi: 10.3390/v15040940
   PubMed Web of Science ®Google Scholar